Kawasaki disease (KD) is a rare but potentially life-threatening condition that affects infants and young children. It is characterised by inflammation of the blood vessels, particularly the coronary arteries, which can lead to severe complications if left untreated. In this article, we will discuss the signs and symptoms of Kawasaki disease, its diagnosis, and the management strategies used to treat this condition.

Signs and Symptoms

Kawasaki disease in infants typically begins with a fever that lasts for at least five days, accompanied by a range of symptoms including:

Rash
Swollen neck glands
Swollen hands and feet
Red eyes, lips, and tongue
Joint pain or swelling
Vomiting, diarrhoea, stomach ache, cough, runny nose, headache, or pain or swelling of the joints

These symptoms can be severe and may not all be present simultaneously. In very young infants, only a few may develop, making diagnosis challenging.

Causes of Kawasaki Disease

The exact cause of Kawasaki disease is unknown, but it is thought to be an immune system reaction triggered by an infection or other environmental factor in genetically predisposed children. Some key points about the causes of Kawasaki disease in infants:

It is more common in infants and young children under five, with a peak incidence between 6 months and two years of age. Infants younger than one year tend to have fewer clinical manifestations of the disease.
Boys are slightly more likely to develop Kawasaki disease than girls.
Children of Asian or Pacific Islander descent have higher rates of Kawasaki disease compared to other ethnicities.
Kawasaki disease is not contagious and cannot be spread from one person to another.
Families may have a genetic link, but no specific genes have been identified as the cause.
Kawasaki disease tends to occur seasonally, with most cases in North America happening in the winter and early spring.

Heart-Related Complications

The most severe and frequent complication of Kawasaki disease in infants is the development of coronary artery involvement, which can lead to aneurysms. If left untreated, Kawasaki disease can lead to serious complications such as inflammation of the blood vessels, which can be particularly dangerous because it can affect the coronary arteries. This can cause a ballooning out of a damaged and weakened blood vessel wall, known as an aneurysm.

Mortality

The mortality rate associated with Kawasaki disease is usually related to cardiovascular complications, but severe involvement of other organs can also occur. In cases that go untreated, the mortality rate can be as high as 2 to 3%.

Other Complications

Kawasaki disease can also affect other systems in the body, including the skin, nervous system, gastrointestinal tract, musculoskeletal system, kidneys, lungs, eyes, and haematological effects. Incomplete Kawasaki disease is more common in infants than in older children, and because of their higher risk for developing coronary artery abnormalities, precise diagnosis is important.

Diagnosis of Kawasaki Disease

Kawasaki disease is diagnosed based on clinical manifestations, and it can be challenging to diagnose, especially in infants younger than one-year-old. Incomplete clinical manifestations in infants are associated with the development of coronary artery abnormalities, making early suspicion and evaluation crucial.

Treatment of Kawasaki Disease

The main treatments for Kawasaki disease in infants include:

Intravenous Immunoglobulin (IVIG): IVIG is a solution of antibodies taken from healthy donors and is given through a vein over 8 to 12 hours. IVIG helps reduce fever and the risk of heart problems associated with Kawasaki disease.
Aspirin: Aspirin is used to ease pain, reduce fever, prevent blood clots, and lower the risk of heart problems. It is prescribed under medical supervision, especially in children under 16 years old, as it can cause side effects like Reye Syndrome.
Corticosteroids: Corticosteroids may be recommended if IVIG is ineffective or if the child is at high risk of heart problems. They contain hormones that have various effects on the body and can help manage the disease in some cases.

After Treatment

After hospital treatment, children are sent home on a low dose of aspirin to take daily for 6 to 8 weeks. Close monitoring, follow-up appointments, and echocardiograms are essential to ensure the child's heart health and recovery. Rest, hydration, and watching for any medication side effects are also important aspects of post-treatment care.

Long-Term Outlook

Children who do not develop aneurysms have an excellent long-term outcome. However, regular monitoring and follow-up are necessary to detect any complications early and ensure the child's continued improvement.

Kawasaki Disease accentuates the importance of early recognition, prompt intervention, and comprehensive management to mitigate its potential morbidity and mortality. By fostering awareness and understanding among parents, caregivers, and healthcare professionals, one can navigate this challenging condition with diligence and efficacy, ensuring the best possible outcomes for affected children.

Frequently Asked Questions About Kawasaki Disease

Q. What is Kawasaki Disease (KD) in infants?
A: Kawasaki Disease is a rare but serious condition that primarily affects children under the age of five. It involves inflammation of the blood vessels throughout the body and can lead to complications, particularly if not treated promptly.

Q. What are the signs and symptoms of Kawasaki Disease in infants?
A: Common symptoms include prolonged fever lasting five or more days, rash, redness in the eyes (conjunctivitis), swelling and redness of the hands and feet, swollen lymph nodes in the neck, and irritation and inflammation of the mouth, lips, and throat.

Q. How is Kawasaki Disease diagnosed in infants?
A: Diagnosis typically involves a combination of clinical signs and symptoms, along with laboratory tests to assess inflammation levels and rule out other conditions. Echocardiography may also be performed to evaluate heart involvement.

Q. What is the treatment for Kawasaki Disease in infants?
A: Treatment often includes intravenous immunoglobulin (IVIG) to reduce inflammation and aspirin therapy to decrease the risk of blood clots. Early treatment is crucial to prevent complications such as coronary artery aneurysms.

Q. What are the potential complications of Kawasaki Disease in infants?
A: Without prompt treatment, Kawasaki Disease can lead to serious complications, including coronary artery aneurysms, which may increase the risk of heart problems such as heart attack or abnormal heart rhythms. Regular follow-up care is essential to monitor heart health.

Reference links:

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3888612/
https://www.nhs.uk/conditions/kawasaki-disease/treatment/
https://www.healthychildren.org/English/health-issues/conditions/heart/Pages/Kawasaki-Disease.aspx
https://www.mayoclinic.org/diseases-conditions/kawasaki-disease/diagnosis-treatment/drc-20354603
https://www.aafp.org/pubs/afp/issues/2015/0315/p365.html